Safety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathy.

Jhaveri, Khushali S; Schlam, Ilana; Holtzman, Noa G; Peravali, Monica; Richardson, Perry K; Dahiya, Saurabh; Malkovska, Vera; Rapoport, Aaron P

Jhaveri, Khushali S; Schlam, Ilana; Holtzman, Noa G; Peravali, Monica; Richardson, Perry K; Dahiya, Saurabh; Malkovska, Vera; Rapoport, Aaron P.

Afiliação

Jhaveri KS; Department of Internal Medicine and.
Schlam I; Department of Hematology Oncology, MedStar Washington Hospital Center, Washington, DC.
Holtzman NG; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Peravali M; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD; and.
Richardson PK; Department of Hematology Oncology, MedStar Washington Hospital Center, Washington, DC.
Dahiya S; Department of Neurology, George Washington University, Washington, DC.
Malkovska V; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD; and.
Rapoport AP; Department of Hematology Oncology, MedStar Washington Hospital Center, Washington, DC.

Blood Adv ; 4(23): 6019-6022, 2020 12 08.

Article em En | MEDLINE | ID: mdl-33284942

Assuntos

Linfoma; Receptores de Antígenos Quiméricos; Humanos; Imunoterapia Adotiva; Linfócitos T

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Linfoma Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google